12-21539232-CAA-CA
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_021957.4(GYS2):c.1890+25delT variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.68 ( 36275 hom., cov: 0)
Exomes 𝑓: 0.76 ( 322768 hom. )
Consequence
GYS2
NM_021957.4 intron
NM_021957.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.00400
Genes affected
GYS2 (HGNC:4707): (glycogen synthase 2) The protein encoded by this gene, liver glycogen synthase, catalyzes the rate-limiting step in the synthesis of glycogen - the transfer of a glucose molecule from UDP-glucose to a terminal branch of the glycogen molecule. Mutations in this gene cause glycogen storage disease type 0 (GSD-0) - a rare type of early childhood fasting hypoglycemia with decreased liver glycogen content. [provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 12-21539232-CA-C is Benign according to our data. Variant chr12-21539232-CA-C is described in ClinVar as [Likely_benign]. Clinvar id is 261469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-21539232-CA-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.762 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GYS2 | NM_021957.4 | c.1890+25delT | intron_variant | ENST00000261195.3 | NP_068776.2 | |||
GYS2 | XM_024448960.2 | c.1890+25delT | intron_variant | XP_024304728.1 | ||||
GYS2 | XM_006719063.4 | c.1659+25delT | intron_variant | XP_006719126.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GYS2 | ENST00000261195.3 | c.1890+25delT | intron_variant | 1 | NM_021957.4 | ENSP00000261195.2 | ||||
ENSG00000285854 | ENST00000647960.1 | n.*1892+25delT | intron_variant | ENSP00000497202.1 | ||||||
SPX | ENST00000649016.1 | n.2724delA | non_coding_transcript_exon_variant | 5/5 |
Frequencies
GnomAD3 genomes AF: 0.680 AC: 102932AN: 151478Hom.: 36256 Cov.: 0
GnomAD3 genomes
AF:
AC:
102932
AN:
151478
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.752 AC: 183494AN: 244042Hom.: 69583 AF XY: 0.753 AC XY: 99276AN XY: 131820
GnomAD3 exomes
AF:
AC:
183494
AN:
244042
Hom.:
AF XY:
AC XY:
99276
AN XY:
131820
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.757 AC: 848202AN: 1120680Hom.: 322768 Cov.: 0 AF XY: 0.757 AC XY: 433810AN XY: 573138
GnomAD4 exome
AF:
AC:
848202
AN:
1120680
Hom.:
Cov.:
0
AF XY:
AC XY:
433810
AN XY:
573138
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.679 AC: 103002AN: 151596Hom.: 36275 Cov.: 0 AF XY: 0.684 AC XY: 50691AN XY: 74072
GnomAD4 genome
AF:
AC:
103002
AN:
151596
Hom.:
Cov.:
0
AF XY:
AC XY:
50691
AN XY:
74072
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Glycogen storage disorder due to hepatic glycogen synthase deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 29, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at